Barings’s Concentrix CNXC Stock Holding History

Barings’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,510	Closed	-$675K	–	404
2021 Q1	$675K	Buy	+4,510	New	+$547K	0.02%	269

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Barings's CNXC Position: Q2 2021 in Review

Barings sold out of Concentrix (CNXC) in Q2 2021, closing a stake of 4,510 shares — an estimated $675K sold.

Barings first reported a position in CNXC in Q1 2021 and held it in 1 quarter. The position peaked at $675K in Q1 2021. 316 funds tracked by Wall St. Rank hold CNXC as of Q2 2021.

Barings reported no remaining Concentrix position as of Q2 2021 after selling out during the quarter.
Barings sold 4,510 Concentrix shares in Q2 2021, an estimated $675K.
Barings first reported a position in Concentrix in Q1 2021 and held it in 1 quarter.
Barings's Concentrix position peaked at $675K in Q1 2021.
316 funds tracked by Wall St. Rank held Concentrix as of Q2 2021.

Based on Barings's 13F filing for Q2 2021, filed 11 Aug 2021.